Approval · Notice of Compliance 790 · 2002
ZOMETA: Notice of Compliance 790
Issued August 7, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 790
- Date
- August 7, 2002
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- New indication: treatment of bone metastases due to prostate cancer in conjunction with standard antineoplastic therapy
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOMETA | Not yet assigned | — |
Medicinal ingredients
- ZOLEDRONIC ACID 4 MG per VIAL